Pemfigus
Patofizjologia i mechanizm

Pemfigus to zagrażająca życiu autoimmunologiczna choroba pęcherzowa, charakteryzująca się akantolizą wywołaną przez autoprzeciwciała IgG (głównie podklasy IgG4) skierowane przeciwko desmogleinom 1 i 3 (Dsg1, Dsg3), które są kluczowymi glikoproteinami desmosomów odpowiedzialnymi za adhezję keratynocytów. Patogeneza obejmuje bezpośrednie zakłócenie adhezji komórkowej przez steryczne utrudnianie interakcji trans-Dsg3, endocytozę Dsg3 indukowaną przez p38MAPK oraz aktywację licznych szlaków sygnałowych, takich jak p38MAPK, PKC, Src, ERK i cAMP. Dodatkowo, autoprzeciwciała wywołują apoptozę keratynocytów poprzez aktywację kaspaz i receptorów Fas, a także piroptoizę, zapalną formę śmierci komórkowej nasilającą akantolizę, z udziałem inflammasomów i cytokin IL-1 oraz IL-18. Dysregulacja osi p53-DSG3, z udziałem białek takich jak ATM, c-Myc i p38MAPK, oraz samonapędzający się mechanizm regulacji ST18, potęgują przewlekłość choroby. W patogenezie istotną rolę odgrywa także odpowiedź immunologiczna Th2, z produkcją IL-4, IL-6, IL-22 i TNF-α, co sprzyja przełączaniu izotypów przeciwciał na patogenną IgG4.

pemfigusa”>Patogeneza pemfigusa

Pemfigus (łac. pemphigus) stanowi grupę zagrażających życiu chorób pęcherzowych, charakteryzujących się akantoliząą (utratą adhezji między keratynocytami), która prowadzi do tworzenia się pęcherzy śródnaskórkowych w błonach śluzowych i skórze. Proces akantolizy jest indukowany przez wiązanie krążących autoprzeciwciał immunoglobuliny G (IgG) do cząsteczek adhezji międzykomórkowej.12 Pomimo licznych badań, mechanizmy patologiczne pemfigusa są nadal niecałkowicie poznane, choć etiologia jest uważana za wieloczynnikową.34

Autoprzeciwciała w pemfigusie

Pemfigus jest chorobą autoimmunologiczną, w której autoantygeny są kierowane przeciwko desmogleinom (DSG), które tworzą „klej” łączący przylegające komórki naskórkowe za pomocą punktów przyczepu zwanych desmosomami. Kiedy autoprzeciwciała atakują desmogleiny, komórki zostają od siebie oddzielone, a naskórek oddziela się, co jest zjawiskiem nazywanym akantoliząą. Powoduje to pęcherze, które złuszczają się i przekształcają w nadżerki.5 Liczne badania potwierdzają koncepcję, że pemfigus jest spowodowany przez patogenne autoprzeciwciała IgG skierowane przeciwko DSG3, jak również DSG1.6

Technikami immunochemicznymi i molekularnymi klonowaniem wykazano, że antygenami w pemfigusie są desmogleiny (Dsgs), glikoproteiny przezbłonowe desmosomów, które umożliwiają adhezję komórka-komórka w naskórku.7 Kluczową rolę antygenu pemfigusa w adhezji keratynocytów wykazano poprzez genetyczną delecję antygenu PV, Dsg3, u myszy i enzymatyczną inaktywację antygenu PF, Dsg1, przez egzotoksynę A (wytwarzaną przez Staphylococcus aureus) u myszy i ludzi.8

Podklasy przeciwciał IgG

Eksperymenty z biernym transferem u myszy potwierdziły patogenność krążących przeciwciał IgG od pacjentów z pemfigusem, które powodują chorobę zależną od dawki i wskazują na przewagę podklasy IgG4 w surowicach pacjentów z PF oraz w indukcji choroby u myszy.9 Dominującą podklasą zaangażowaną w patogenezę pemfigusa jest IgG4, niezależnie od typu pemfigusa, co zostało ocenione zarówno metodą bezpośredniej immunofluorescencji (DIF), jak i pośredniej immunofluorescencji (IIF) z wykorzystaniem normalnej ludzkiej skóry brzucha jako substratu.10 Autoantibody w FS są oparte na IgG i są głównie podklasy IgG4.11

Mechanizmy molekularne akantolizy

Liczne dane sugerują, że niektóre przeciwciała pemfigusa bezpośrednio zakłócają adhezję komórkową. Mechanistycznie, wykazano, że niektóre autoantibody PV bezpośrednio ingerują w homofilne interakcje trans-cząsteczek Dsg3, prawdopodobnie poprzez steryczne utrudnianie adhezji Dsg.12 Model ten nazywany jest hipotezą niezmontowanego wyczerpania Dsg. Model ten przypisuje utratę adhezji komórkowej zdolności wielowartościowych przeciwciał anty-Dsg pemfigusa do wiązania krzyżowego i grupowania Dsgs.13

Fosforylacja DSG3 jest spowodowana wiązaniem patogennych PV IgG do DSG3, po czym następuje jego dysocjacja od plakoglobiny, a następnie degradacja mediowana przez endocytozę.1415 Zakłócenie tego procesu remodelowania, w tym aktywacja wyżej wymienionych szlaków sygnałowych, zostało zgłoszone w PV.16

Rola desmoglein w patogenezie

Desmogleiny 1 i 3 są członkami rodziny kadheryn – cząsteczek adhezji. Są to białka przezbłonowe, które oddziałują z plakoglobiną, składnikiem gęstej płytki desmosomu. Uważa się, że przeciwciała przeciwko Dsg3 i Dsg1 bezpośrednio indukują akantoliząę, zakłócając funkcję adhezyjną tych cząsteczek docelowych.17 Głównym antygenem w PV jest Dsg3 (130 kDa), ale 50% pacjentów ma również autoprzeciwciała przeciwko Dsg1 (160 kDa). Stosunek przeciwciał Dsg1 i Dsg3 wydaje się korelować z kliniczną ciężkością PV; u osób z przeciwciałami tylko przeciwko Dsg3 dominują zmiany w jamie ustnej.18

Lokalizacja tworzenia się pęcherzy i zajęcia powierzchni śluzówkowych różni się w zależności od podtypu choroby pemfigus i może być wyjaśniona teorią kompensacji Dsg. Teoria ta stwierdza, że na powierzchniach skórnych Dsg1 jest ekspresjonowana we wszystkich warstwach naskórka, podczas gdy Dsg3 jest ekspresjonowana w głębszych warstwach. Ekspresja Dsg1 w błonie śluzowej jest minimalna, podczas gdy Dsg3 jest dominująca.19

Interpretacja teorii kompensacji Dsg w odniesieniu do manifestacji klinicznych w pemfigusie można podsumować następująco: Tylko pacjenci z przeciwciałami przeciwko Dsg3 powinni mieć dominujący błoną śluzową PV, ponieważ Dsg1 kompensuje utratę Dsg3 w skórze. Błony śluzowe zawierają głównie Dsg3; niskie poziomy Dsg1 w błonie śluzowej nie mogą zastąpić utraconego Dsg3 i prowadzą do akantolizy nabłonkowej i nadżerek błony śluzowej. Gdy rozwijają się przeciwciała przeciwko zarówno Dsg1, jak i Dsg3, akantoliząa naskórkowa występuje zarówno w skórze, jak i błonach śluzowych.20

Sygnalizacja komórkowa w akantolizie

Wczesne dowody wskazujące na mechanizmy sygnalizacji wewnątrzkomórkowej w indukcji akantolizy pochodziły z obserwacji, że poliklonalne IgG PV powoduje retrakcję włókien pośrednich keratyny w hodowanych keratynocytach myszy typu dzikiego, ale nie u myszy z niedoborem PG.21 Ta kaskada sygnałowa była również aktywna w skórze pacjentów z PV i PF.22

Indukcja akantolizy jest aktywnym procesem, który wydaje się być bardziej złożony niż prosta interakcja przeciwciał z cząsteczkami adhezji. Zdarzenia sygnalizacyjne związane z wiązaniem surowicy PV do keratynocytów obejmują aktywację fosfolipazy C, co prowadzi do wzrostu zarówno inositolu 1,4,5-trifosforanu (IP3), jak i diacyloglicerolu (DAG).23

Wiązanie PV IgG do DSG3, jak wykazano, stymuluje szlak sygnałowy fosfolipazy C, co powoduje uwalnianie wapnia i aktywację PKC, prowadząc ostatecznie do zubożenia desmosomów i powierzchniowego DSG3, a także do utraty kohezji międzykomórkowej i tworzenia się pęcherzy.24

Rola p53 i YAP w patogenezie pemfigusa

Najnowsze badania odkryły nowe aktywności DSG3 w regulacji p53 i białka związanego z Yes (YAP), z dowodami dysregulacji tych szlaków wykazanymi w PV.2526 Rehman i wsp. zidentyfikowali DSG3 działającą jako białko antystresowe poprzez przeciwdziałanie p53 w utrzymaniu normalnej homeostazy nabłonkowej i wykazali zakłócenie tej regulacji w PV.2728 Badanie to odnosi się do długotrwałej kontrowersji w dziedzinie badań nad pemfigusem i wypełnia lukę w związku między DSG3 a p53.2930

Wskazuje to, że sama utrata/zakłócenie DSG3 jest wystarczająca do wywołania nieprawidłowej odpowiedzi p53, a tym samym zakłócenie połączeń międzykomórkowych mediowanych przez DSG3 nie wynika wyłącznie z przeszkody sterycznej, ale raczej powoduje dysfunkcję komórkowej odpowiedzi antystresowej.31

Dlatego zakłócenie tego szlaku może odgrywać ważną rolę w patologii PV. Łącznie prawdopodobne jest, że autoprzeciwciała PV ukierunkowane na DSG3 wpływają na jego funkcję w sieci antystresowej, co prowadzi do nierównowagi oksydacyjnej/antyoksydacyjnej w komórkach.3233 W konsekwencji stres oksydacyjny może wystąpić w komórkach PV, powodując podwójnołańcuchowe pęknięcia DNA (DSB), a następnie aktywację łańcucha reakcji, w tym ATM, c-Myc i p38 MAPK, a następnie wywołuje szlak p53 prowadzący do deregulacji maszynerii apoptotycznej i tworzenia pęcherzy PV.34

Rola ST18 w patogenezie

Pemfigus zwykły (PV) jest zagrażającą życiu autoimmunologiczną chorobą pęcherzową błon śluzowowych i skóry, która w dużej mierze jest genetycznie uwarunkowana i wynika, przynajmniej częściowo, z szkodliwej aktywności autoprzeciwciał skierowanych przeciwko desmogleinie (DSG)3, prominentnej cząsteczce adhezji wewnątrznaskórkowej.35

Wcześniej wykazano, że rs17315309, silny wariant ryzyka dla PV w promotorze genu czynnika transkrypcyjnego ST18, promuje regulację w górę ST18 w naskórku w sposób zależny od p53/p63. Zwiększona ekspresja ST18 znacznie zwiększa utratę kohezji keratynocytów mediowaną przez autoprzeciwciała PV.36

Nadekspresja ST18 znacząco zwiększa regulację w dół DSG3 mediowaną przez autoprzeciwciała w keratynocytach. Zmniejszona ekspresja DSG3 wzmacnia funkcję p53 poprzez aktywację kinazy białkowej aktywowanej przez mitogen p38 (p38MAPK) i dramatycznie zwiększa aktywność promotora ST18 zależną od p53.3738

Fakt, że regulacja w dół DSG3 stymuluje ekspresję p53 w sposób zależny od p38MAPK, przygotowuje grunt pod samonapędzający się mechanizm, który wyjaśnia przewlekłość PV. Tak więc, ST18 odgrywa kluczową rolę w propagacji autoimmunizacji w PV.39

Rola kinaz w patogenezie pemfigusa

Zidentyfikowano sygnalizację wewnątrzkomórkową kinazy w patogennym procesie PV. Wiązanie autoprzeciwciał w PV promuje fosforylację kinaz.40 W badaniu, w którym badano pacjentów z diagnozą PV, stwierdzono fosforylację kinaz (np. fosfokinazy C (PKC), kinazy białkowej aktywowanej przez mitogen p38 (p38MAPK), kinazy zależnej od cykliny (Cdk2), kinazy związanej z mięsakiem (Src), kinazy regulowanej przez sygnał zewnątrzkomórkowy (ERK), kinazy tyrozynowej Brutona (BTK), kinazy regulacyjnej sygnału apoptozy (ASK1), kinazy receptora naskórkowego czynnika wzrostu (EFGRK)), kinazy tyrozynowej (TK)) w modelach indukowanych PV.41 Hamowanie tych szlaków zmniejsza akantoliząę in vitro i in vivo.42

Rola p38MAPK została podkreślona w wielu badaniach. p38MAPK jest aktywowana po wiązaniu PVIgG w górnej części kinazy Rho. W szczególności, hamowanie p38MAPK zapobiega redystrybucji Dsg3 indukowanej przez PV-IgG i powoduje kolokalizację PV-IgG i Dsg3 na błonie komórkowej. W rezultacie, wykazano, że hamowanie p38MAPK zapobiega tworzeniu się pęcherzy zarówno histologicznych, jak i klinicznych, zarówno w modelach in vivo, jak i in vitro. Dlatego p38MAPK odgrywa istotną rolę w regulacji internalizacji Dsg3 i musi być uważane za kluczowy składnik w patogenności PV.43

Szlaki sygnałowe w pemfigusie

Wszystkie frakcje PV-IgG i AK23 (monoklonalne przeciwciało myszy przeciwko Dsg3) osłabiały wiązanie Dsg3, ale nie Dsg1, i zwiększały aktywność Src. Z drugiej strony, szybki napływ Ca2+ i aktywacja Erk były indukowane przez mukokutanowe PV-IgG i IgG pemfigusa liściowatego (PF) (aDsg1), podczas gdy cAMP był zwiększony tylko przez śluzówkowe i mukokutanowe PV-IgG.44

Selektywne hamowanie p38MAPK, Src lub PKC blokowało utratę kohezji keratynocytów w odpowiedzi na wszystkie frakcje autoprzeciwciał, podczas gdy hamowanie Erk było ochronne tylko przeciwko mukokutanowym PV-IgG i PF-IgG.45 Wyniki te pokazują, że wzorce sygnalizacyjne są równoległe do fenotypu klinicznego, ponieważ niektóre mechanizmy zaangażowane w utratę kohezji komórkowej są spowodowane przez przeciwciała ukierunkowane na Dsg3, podczas gdy inne korelują z autoprzeciwciałami przeciwko Dsg1.46

Wzorce sygnalizacyjne zidentyfikowane tutaj wydają się być złożone. Aktywację p38MAPK stwierdzono we wszystkich stanach patologicznych, co jest zgodne ze wszystkimi publikacjami, w których zgłoszono rolę tego szlaku w patogenezie pemfigusa w dół PV-IgG, PF-IgG i AK23. Wskazuje to, że przeciwciała przeciwko Dsg3, jak również frakcje autoprzeciwciał zawierające aDsg1, ale nie aDsg3, mogą aktywować sygnalizację p38MAPK.47

Apoptoza i piroptoiza w pemfigusie

Szlak apoptozy w PV jest udowodniony przez badania eksperymentalne, które wykazują, że sygnalizacja apoptotyczna jest aktywowana przez autoprzeciwciało PV i przeciwciało anty-receptor Fas (FasR).48 Najnowsze badania odkryły, że apoptoza była opisana jako możliwy podstawowy mechanizm akantolizy. Podobnie, apoptoliza jest uważana za powiązanie między suprabazalną akantolityczną a drogami śmierci komórkowej.4950

Kaspazy są zaangażowane w patogenezę PV poprzez apoptozę i akantoliząę. Kaspazy są aktywowane przez różne szlaki komórkowe, aby wpływać na programowaną śmierć komórki. Podczas gdy apoptoza za pośrednictwem kaspaz jest normalnym procesem w organizmie, obecność PV-IgG powoduje patologiczną aktywację kaspaz w keratynocytach. We wszystkich badaniach wykazano, że hamowanie kaspaz zmniejsza apoptozę i akantoliząę, a tym samym ma pozytywny wpływ na adhezję komórka-komórka.51

Najnowsze badania wykazały, że piroptoiza keratynocytów może nasilać akantoliząę i opóźniać gojenie się ran.52 Obecne odkrycia podkreślają znaczącą regulację w górę białek związanych z piroptoząą, które odgrywają kluczową rolę w odpowiedzi zapalnej i tworzeniu pęcherzy charakterystycznym dla pemfigusa.53 Piroptoiza znacząco przyczynia się do patogenezy pemfigusa i stanowi obiecujący cel dla terapii.54

Mechanizmy piroptozy

Piroptoiza jest powodowana przez aktywację inflamasomów za pośrednictwem dwóch głównych szlaków: klasycznego i nieklasycznego.55 Związek między piroptoząą a akantoliząą może przede wszystkim obracać się wokół odpowiedzi zapalnej wywołanej przez piroptozę i jej szkodliwego wpływu na integralność tkanki skórnej.56

Piroptoiza jest powszechnie aktywowana w odpowiedzi na patogeny wewnątrzkomórkowe, powodując zapalenie skóry.57 Podwyższone poziomy cytokin zapalnych, w tym IL-18 i IL-1, zostały udokumentowane w kilku chorobach skóry, sugerując ich potencjalną rolę w łączeniu piroptozy z akantoliząą.58 Eksploracja roli piroptozy w patogenezie pemfigusa i jej implikacji terapeutycznych wymaga głębszego zagłębienia się w aktywację kaspazy i jak inhibitory kaspazy, szczególnie te ukierunkowane na kaspazę-1, mogą pomóc w leczeniu choroby.59

Rola komórek T w patogenezie pemfigusa

Istnieje silne powiązanie między pewnymi allelami ludzkiego antygenu leukocytarnego (HLA) klasy II a podatnością na PV.60 Dane te sugerują, że pacjenci, którzy rozwijają chorobę, muszą mieć cząsteczki klasy II HLA zdolne do prezentowania peptydów Dsg3 komórkom T.61

Patogeneza pemfigusa obejmuje produkcję aktywowanych komórek B i IgG ze stymulacją przez IL-4 przez komórki T pomocnicze 2 (Th2). Nadmierna aktywacja komórek Th2 powoduje produkcję autoprzeciwciał wymaganych dla PV. Komórki Th2 wydzielają IL-4 i wiele interleukin (IL), które, jak wiadomo, odgrywają ważną rolę w pemfigusie.62

IL-4 promuje produkcję przeciwciał przez specyficzne komórki B i przełączanie izotypów z przeciwciał IgG1 na IgG4, które są ważne w aktywnej formie PV. IL-4 powoduje również różnicowanie naiwnych komórek T CD4+ w komórki Th2, utrzymując w ten sposób chorobę. Produkcja autoprzeciwciał i wiązanie epitopów są wystarczające do bezpośredniej utraty adhezji między desmosomami.63

Pemfigus będąc chorobą autoimmunologiczną napędzaną przez autoprzeciwciała przeciwko antygenowi naskórkowemu, oczekuje się z immunologicznego punktu widzenia, że obserwowana będzie przewaga Th2.64

Czynniki genetyczne

Czynniki genetyczne są zaangażowane w patogenezę, z allelami HLADR4 (DRB1*0402) i HLADRw6 (DQB1*0503) częściej występującymi u pacjentów z pemfigusem zwykłym, HLA klasy II DRB1*0344 i HLA Cw*1445 skorelowane z pemfigusem paraneoplastycznym oraz HLADRB1*04:01, HLADRB1*04:06, HLADRB1*01:01, HLADRB1*14, związane z wyższym ryzykiem rozwoju pemfigusa liściowatego.65

Wyższa częstość występowania PV i wcześniejszy wiek zachorowania na pemfigusa obserwowany w populacji indyjskiej przypisuje się wyższej częstości DSG3FNx01TCCCC w populacji indyjskiej. W analizie asocjacyjnej haplotypów polimorfizmu pojedynczego nukleotydu wewnątrz genu w celu oceny wkładu allelu Dsg3 w podatność na PV, zaobserwowano, że dwa spokrewnione haplotypy, DSG3FNx01TCCTC i DSG3FNx01TCCCC, były zaangażowane w patogenezę PV u pacjentów odpowiednio brytyjskiego i północno-indyjskiego pochodzenia.66

Lokalne mikrośrodowisko immunologiczne

Pemfigus jest autoimmunologiczną chorobą skóry. Ektopowe struktury podobne do limfoidalnych (ELS) okazały się powszechnie obecne w zmianach pemfigusa, prawdopodobnie wspierając produkcję przeciwciał specyficznych dla desmogleiny (Dsg) in situ. Jednak fenotypy funkcjonalne i regulatory agregatów limfoidalnych w zmianach pemfigusa pozostają w dużej mierze nieznane.67

Nasze odkrycia potwierdzają udział lokalnej dysregulacji immunologicznej i zmienionego składu komórek immunologicznych jako potencjalnych czynników napędzających zmiany pemfigusa. Ponadto, skonstruowano sieć konkurencyjnego RNA endogennego (ceRNA) mediowaną przez lncRNA i zidentyfikowano regulatory epigenetyczne, takie jak LINC01588, które mogą modulować równowagę Treg/Th17 za pośrednictwem szlaku sygnałowego PPAR.68

Porównano również wyniki analizy funkcjonalnej SIMC z wynikami PBMC, aby lepiej zrozumieć unikalne role SIMC. Wyniki analizy GO wykazały, że PBMC miały nadreprezentację cytokin zapalnych i chemokin, podczas gdy SIMC miały sygnaturę agregacji neutrofilów i innych szlaków związanych z metabolizmem. Wyniki te wskazują, że SIMC i PBMC miały znacznie różne fenotypy funkcjonalne.69

Interesujące jest to, że SIMC i PBMC wykazywały podobieństwo w wynikach KEGG. Szlak sygnałowy IL-17 był nadreprezentowany zarówno w SIMC, jak i PBMC, co jest zgodne z wcześniejszymi doniesieniami.70 Badanie to jest również pierwszym, które wykazuje zwiększoną infiltrację komórek NK w zmianach pemfigusa. Ponadto, stwierdzono, że LINC10588 był negatywnie skorelowany z sygnalizacją PPAR, co może być związane z patogenezą pemfigusa.71

Mechanizm patogenetyczny Opis Związane molekuły
Autoprzeciwciała przeciwko desmogleinom Główny mechanizm powodujący utratę adhezji między keratynocytami Dsg1, Dsg3, IgG (głównie IgG4)
Bezpośrednie zakłócenie adhezji komórkowej Steryczne utrudnienie interakcji trans-Dsg3 Przeciwciała anty-Dsg
Endocytoza Dsg Zmniejszenie powierzchniowego Dsg3 poprzez internalizację Przeciwciała anty-Dsg, p38MAPK
Aktywacja szlaków sygnałowych Aktywacja wewnątrzkomórkowych kinaz i kaskad sygnałowych p38MAPK, PKC, Src, ERK, cAMP
Apoptoza keratynocytów Programowana śmierć komórkowa w odpowiedzi na autoprzeciwciała Kaspazy, FasR, czynniki apoptotyczne
Piroptoiza Zapalna forma śmierci komórkowej nasilająca akantoliząę Inflammasomy, kaspaza-1, IL-1, IL-18
Szlak p53-DSG3 Zakłócenie równowagi między DSG3 a p53 w odpowiedzi na stres p53, DSG3, ATM, c-Myc, p38MAPK
Regulacja ST18 Samonapędzający się cykl aktywacji ST18 i redukcji DSG3 ST18, p53, p38MAPK, DSG3
Odpowiedź Th2 Produkcja autoprzeciwciał przez aktywowane komórki B IL-4, IL-6, IL-22, TNF-α, komórki Th2

Mechanizmy patogenezy

Mechanizmy patologiczne pemfigusa są złożone i nadal nie są całkowicie jasne.72 Nasze ostatnie badania rzucają nowe światło na bezprecedensowe role DSG3 i sugerują jego pośredniczącą sygnalizację w kierunku p53, YAP i ROS w komórkowej odpowiedzi na stres, z dowodami dysregulacji tych osi wykazanej w PV.73

Wiele szlaków sygnałowych działa w rozwoju akantolizy pemfigusa.74 Teoria ta eksploruje nowe mechanizmy z odkryciami uzyskanymi przez niezależne grupy.75 Podsumowując, Dsgs są kluczowymi antygenami docelowymi, chociaż eksplorowane są również inne autoantygeny. Ważne jest, że te autoantygeny nie mogą wywołać pemfigusa same, bez obecności przeciwciał anty-Dsg; niemniej jednak mogą pogorszyć chorobę. Dlatego to podsumowanie sugeruje, że uszkodzenie strukturalne (akantoliząa) i śmierć (apoptoza) keratynocytów w pemfigusie są mediowane przez ten sam zestaw enzymów śmierci komórkowej.76

Istnieją liczne mechanizmy w patogenezie PV, które nadal nie są zrozumiane i potrzebne są więcej badań.77 Patofizjologia i profil autoantygenu chorób autoimmunologicznych pęcherzowych, zwłaszcza pemfigusa i jego podform, są bardziej złożone niż wcześniej zakładano.78

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 11.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Pathogenesis, clinical manifestations, and diagnosis of pemphigus – UpToDate
    https://www.uptodate.com/contents/pathogenesis-clinical-manifestations-and-diagnosis-of-pemphigus
    Pemphigus is defined as a group of life-threatening blistering disorders characterized by acantholysis (loss of keratinocyte to keratinocyte adhesion) that results in the formation of intraepithelial blisters in mucous membranes and skin. The process of acantholysis is induced by the binding of circulating immunoglobulin G (IgG) autoantibodies to intercellular adhesion molecules. […] The pathogenesis, clinical features, and diagnosis of pemphigus will be discussed here. […] The different forms of pemphigus are distinguished by their clinical features, associated autoantigens, and laboratory findings.
  • #2 Pathogenesis, clinical manifestations, and diagnosis of pemphigus – UpToDate
    https://www.uptodate.com/contents/pathogenesis-clinical-manifestations-and-diagnosis-of-pemphigus/print
    Pemphigus is defined as a group of life-threatening blistering disorders characterized by acantholysis (loss of keratinocyte to keratinocyte adhesion) that results in the formation of intraepithelial blisters in mucous membranes and skin. The process of acantholysis is induced by the binding of circulating immunoglobulin G (IgG) autoantibodies to intercellular adhesion molecules. […] The pathogenesis, clinical features, and diagnosis of pemphigus will be discussed here.
  • #3 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8303937/
    The immunobullous condition Pemphigus Vulgaris (PV) is caused by autoantibodies targeting the adhesion proteins of desmosomes, leading to blistering in the skin and mucosal membrane. […] Despite numerous investigations, the pathological mechanisms of PV are still incompletely understood, though the etiology is thought to be multifactorial. […] Ample studies have highlighted the role of Desmoglein-3 (DSG3) in the initiation of disease as DSG3 serves as a primary target of PV autoantibodies. […] Recent studies have uncovered new activities of DSG3 in regulating p53 and the yes-associated protein (YAP), with the evidence of dysregulation of these pathways demonstrated in PV. […] The pathological mechanisms of PV are controversial and remain a hot topic under debate in the field. […] Various signaling pathways are at play in the development of pemphigus acantholysis.
  • #4 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://www.mdpi.com/2075-1729/11/7/621
    The immunobullous condition Pemphigus Vulgaris (PV) is caused by autoantibodies targeting the adhesion proteins of desmosomes, leading to blistering in the skin and mucosal membrane. […] Despite numerous investigations, the pathological mechanisms of PV are still incompletely understood, though the etiology is thought to be multifactorial. […] Ample studies have highlighted the role of Desmoglein-3 (DSG3) in the initiation of disease as DSG3 serves as a primary target of PV autoantibodies. […] Recent studies have uncovered new activities of DSG3 in regulating p53 and the yes-associated protein (YAP), with the evidence of dysregulation of these pathways demonstrated in PV. […] The pathological mechanisms of PV are controversial and remain a hot topic under debate in the field. […] Ample studies support the concept that PV is caused by the pathogenic IgG autoantibodies directed against DSG3 as well as DSG1.
  • #5 Pemphigus – Wikipedia
    https://en.wikipedia.org/wiki/Pemphigus
    Pemphigus, from 1886 medical book Microscopic image of direct immunofluorescence using an anti-IgG antibody. The tissue is skin from a patient with Pemphigus vulgaris. Note the intercellular IgG deposits in the epidermis and the early intraepidermal vesicle caused by acantholysis. Pemphigus is a rare group of blistering autoimmune diseases that affect the skin and mucous membranes. In pemphigus, autoantibodies form against desmoglein, which forms the „glue” that attaches adjacent epidermal cells via attachment points called desmosomes. When autoantibodies attack desmogleins, the cells become separated from each other and the epidermis becomes detached, a phenomenon called acantholysis. This causes blisters that slough off and turn into sores. […] Pemphigus defines a group of autoimmune intraepithelial blistering diseases that are characterized by loss of normal cell-cell adhesion (acantholysis), and by the presence of pathogenic (predominantly IgG) autoantibodies reacting against epithelial adhesion molecules. […] Definitive diagnosis also requires the demonstration of antidesmoglein autoantibodies by direct immunofluorescence on the skin biopsy. These antibodies appear as IgG deposits along the desmosomes between epidermal cells, a pattern reminiscent of chicken wire.
  • #6 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://www.mdpi.com/2075-1729/11/7/621
    The immunobullous condition Pemphigus Vulgaris (PV) is caused by autoantibodies targeting the adhesion proteins of desmosomes, leading to blistering in the skin and mucosal membrane. […] Despite numerous investigations, the pathological mechanisms of PV are still incompletely understood, though the etiology is thought to be multifactorial. […] Ample studies have highlighted the role of Desmoglein-3 (DSG3) in the initiation of disease as DSG3 serves as a primary target of PV autoantibodies. […] Recent studies have uncovered new activities of DSG3 in regulating p53 and the yes-associated protein (YAP), with the evidence of dysregulation of these pathways demonstrated in PV. […] The pathological mechanisms of PV are controversial and remain a hot topic under debate in the field. […] Ample studies support the concept that PV is caused by the pathogenic IgG autoantibodies directed against DSG3 as well as DSG1.
  • #7 Mechanisms of Disease: Pemphigus and Bullous Pemphigoid
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5560122/
    Pemphigus and bullous pemphigoid are autoantibody-mediated blistering skin diseases. In pemphigus, keratinocytes in epidermis and mucous membranes lose cell-cell adhesion, and in pemphigoid, the basal keratinocytes lose adhesion to the basement membrane. Pemphigus lesions are mediated directly by the autoantibodies, whereas the autoantibodies in pemphigoid fix complement and mediate inflammation. […] Understanding these mechanisms of disease has led to rational targeted therapeutic strategies. […] Immunochemical and molecular cloning techniques have shown that the antigens in pemphigus are desmogleins (Dsgs), transmembrane glycoproteins of desmosomes that confer cell-cell adhesion within the epidermis. […] The pivotal role of the pemphigus antigens for keratinocyte adhesion has been shown by genetic deletion of the PV antigen, Dsg3, in mice and enzymatic inactivation of the PF antigen, Dsg1, by exfoliative toxin A (produced by Staphylococcus aureus) in mice and humans.
  • #8 Mechanisms of Disease: Pemphigus and Bullous Pemphigoid
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5560122/
    Pemphigus and bullous pemphigoid are autoantibody-mediated blistering skin diseases. In pemphigus, keratinocytes in epidermis and mucous membranes lose cell-cell adhesion, and in pemphigoid, the basal keratinocytes lose adhesion to the basement membrane. Pemphigus lesions are mediated directly by the autoantibodies, whereas the autoantibodies in pemphigoid fix complement and mediate inflammation. […] Understanding these mechanisms of disease has led to rational targeted therapeutic strategies. […] Immunochemical and molecular cloning techniques have shown that the antigens in pemphigus are desmogleins (Dsgs), transmembrane glycoproteins of desmosomes that confer cell-cell adhesion within the epidermis. […] The pivotal role of the pemphigus antigens for keratinocyte adhesion has been shown by genetic deletion of the PV antigen, Dsg3, in mice and enzymatic inactivation of the PF antigen, Dsg1, by exfoliative toxin A (produced by Staphylococcus aureus) in mice and humans.
  • #9 Mechanisms of Disease: Pemphigus and Bullous Pemphigoid
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5560122/
    Passive transfer experiments in mice have confirmed the pathogenicity of circulating IgG antibodies from pemphigus patients, which result in dose-dependent disease and point to a predominance of the IgG4 subclass in PF patients’ sera and in disease induction among mice. […] The observation of neonatal PV in babies born to mothers with PV corresponds to a passive transfer experiment in humans. […] Dissection of the serum autoantibody profiles in pemphigus patients led to the observation that PV patients show a dual status of serum antibodies. […] These autoantibody profiles, combined with the determination of the normal tissue distributions of Dsg3 and Dsg1, led to the desmoglein compensation model to explain the distinct histological sites of blister formation in mucosal PV, mucocutaneous PV, and PF.
  • #10 Pemphigus in India – Indian Journal of Dermatology, Venereology and Leprology
    https://ijdvl.com/pemphigus-in-india/
    Pemphigus being an autoimmune disease driven by autoantibody against epidermal antigen, it is expected from immunological point of view that Th2 predominance would be observed. […] The predominant subclass involved in pathogenesis of pemphigus is IgG 4 irrespective of type of pemphigus, as was assessed by direct immunofluorescence (DIF) as well as indirect immunofluorescence (IIF) study using normal human abdominal skin as substrate.
  • #11 Pathogenesis of Endemic Pemphigus Foliaceus | Plastic Surgery Key
    https://plasticsurgerykey.com/pathogenesis-of-endemic-pemphigus-foliaceus/
    The autoantibody response in FS is based on IgG, and is predominantly of the IgG4 subclass. […] Total IgG4, F(ab)2, and Fab fragments of FS IgG are all pathogenic in the FS mouse model. […] Anti-Dsg1 antibodies are detected not only in the sera of FS patients, but also in normal controls that live in endemic areas. […] At the molecular level, FS immunopathogenesis presents as an epitope-spreading model. […] When analyzing preclinical stages of FS, EC-5 remains the major domain involved in the autoimmune response; however, intramolecular spreading may occur at the disease onset, leading to an EC1-2 oriented IgG response.
  • #12 Mechanisms of Disease: Pemphigus and Bullous Pemphigoid
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5560122/
    Abundant data suggest that some pemphigus antibodies directly interfere with cell adhesion. […] Mechanistically, some PV autoantibodies have been shown to interfere directly with homophilic trans-interaction of Dsg3 molecules, presumably through steric hindrance of Dsg adhesion. […] The model discussed here has been called the Dsg nonassembly depletion hypothesis. […] This model attributes loss of cell adhesion to the ability of multivalent pemphigus anti-Dsg antibodies to crosslink and cluster Dsgs. […] Early evidence implicating intracellular signaling mechanisms in induction of acantholysis came from the observation that polyclonal PV IgG causes retraction of keratin intermediate filaments in cultured keratinocytes from wild-type mice but not from PG-deficient mice. […] This signaling cascade was also shown to be active in PV and PF patients’ skin.
  • #13 Mechanisms of Disease: Pemphigus and Bullous Pemphigoid
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5560122/
    Abundant data suggest that some pemphigus antibodies directly interfere with cell adhesion. […] Mechanistically, some PV autoantibodies have been shown to interfere directly with homophilic trans-interaction of Dsg3 molecules, presumably through steric hindrance of Dsg adhesion. […] The model discussed here has been called the Dsg nonassembly depletion hypothesis. […] This model attributes loss of cell adhesion to the ability of multivalent pemphigus anti-Dsg antibodies to crosslink and cluster Dsgs. […] Early evidence implicating intracellular signaling mechanisms in induction of acantholysis came from the observation that polyclonal PV IgG causes retraction of keratin intermediate filaments in cultured keratinocytes from wild-type mice but not from PG-deficient mice. […] This signaling cascade was also shown to be active in PV and PF patients’ skin.
  • #14 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8303937/
    The phosphorylation of DSG3 is caused by the binding of pathogenic PV IgGs to DSG3 followed by its dissociation from plakoglobin and then endocytosis-mediated degradation. […] This theory explores new mechanisms with the findings obtained by independent groups. […] Rehman et al. have identified DSG3 acting as an anti-stress protein by counterbalancing p53 in the maintenance of normal epithelial homeostasis and demonstrated disruption of this regulation in PV. […] The study addresses the long-term controversy in the field of pemphigus research and fills the gap for the link between DSG3 and p53. […] It indicates that the loss/disruption of DSG3 alone is sufficient to induce aberrant p53 response and thus the disruption of DSG3 mediated intercellular junctions does not result solely from steric hindrance but rather causes dysfunction of cellular anti-stress response.
  • #15 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://www.mdpi.com/2075-1729/11/7/621
    The phosphorylation of DSG3 is caused by the binding of pathogenic PV IgGs to DSG3 followed by its dissociation from plakoglobin and then endocytosis-mediated degradation. […] Disruption of this remodeling process including the activation of the above-mentioned signaling pathways has been reported in PV. […] The apoptosis pathway in PV is proved by experimental studies that demonstrate that apoptotic signaling is activated by PV autoantibody and anti-Fas receptor (FasR) antibody. […] Rehman et al. have identified DSG3 acting as an anti-stress protein by counterbalancing p53 in the maintenance of normal epithelial homeostasis and demonstrated disruption of this regulation in PV. […] The study addresses the long-term controversy in the field of pemphigus research and fills the gap for the link between DSG3 and p53.
  • #16 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://www.mdpi.com/2075-1729/11/7/621
    The phosphorylation of DSG3 is caused by the binding of pathogenic PV IgGs to DSG3 followed by its dissociation from plakoglobin and then endocytosis-mediated degradation. […] Disruption of this remodeling process including the activation of the above-mentioned signaling pathways has been reported in PV. […] The apoptosis pathway in PV is proved by experimental studies that demonstrate that apoptotic signaling is activated by PV autoantibody and anti-Fas receptor (FasR) antibody. […] Rehman et al. have identified DSG3 acting as an anti-stress protein by counterbalancing p53 in the maintenance of normal epithelial homeostasis and demonstrated disruption of this regulation in PV. […] The study addresses the long-term controversy in the field of pemphigus research and fills the gap for the link between DSG3 and p53.
  • #17
    https://www.jci.org/articles/view/11828
    Desmogleins 1 and 3 are members of the cadherin family of adhesion molecules. They are transmembrane proteins that interact with plakoglobin, a component of the dense plaque of the desmosome. It is believed that antibodies to Dsg3 and Dsg1 directly induce acantholysis by interfering with the adhesive function of these target molecules. […] Induction of acantholysis is an active process that appears to be more complex than the simple interaction of antibodies with adhesion molecules. Signaling events associated with binding of PV sera to keratinocytes include activation of phospholipase C, resulting in increases in both inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). […] Grando and colleagues have proposed that blistering in PV is the result of synergy between anti-desmoglein antibodies and anticholinergic receptor antibodies. Antibodies to keratinocyte cholinergic receptors induce acantholysis, in this view, while antibodies to Dsg3 deplete Dsg3 from desmosomes. […] The work of Nguyen et al. raises a number of crucial questions about the pathogenesis of blistering in PV and PF.
  • #18 Pemphigus Vulgaris | IntechOpen
    https://www.intechopen.com/chapters/81673
    Pemphigus vulgaris is an autoimmune condition that is more likely to develop in patients with certain HLA types after triggers. Central to the pathogenesis of pemphigus is the presence of immunoglobulin (Ig) antibodies against proteins on the cell surface of keratinocytes. Immunochemical and molecular cloning studies have shown that antigenic targets in PV are desmogleins. Desmogleins (Dsg) are desmosome-associated transmembrane glycoproteins that provide cell-cell adhesion in the epidermis. The main antigen in PV is Dsg3 (130 kDa), but 50% of patients also have autoantibodies against Dsg1 (160 kDa). The ratio of Dsg1 and Dsg3 antibodies appear to correlate with the clinical severity of PV; those with only Dsg3 antibodies have predominantly oral lesions. IgG antibodies against Dsgs impair the adhesive function of desmosomes and inhibit cell-cell adhesion. This results in epidermal acantholysis and drooping blister formation, which is the characteristic clinical feature of pemphigus diseases.
  • #19 Pemphigus Vulgaris | IntechOpen
    https://www.intechopen.com/chapters/81673
    The localization of blister formation and involvement of mucosal surfaces varies with the pemphigus disease subtype and can be explained by the Dsg compensation theory. This theory states that on cutaneous surfaces, Dsg 1 is expressed in all layers of the epidermis, while Dsg 3 is expressed in deeper layers. Dsg 1 expression in the mucosa is minimal, while Dsg 3 is dominant. The interpretation of the Dsg compensation theory, as it relates to the clinical manifestations in pemphigus, can be summarized as follows: Only patients with antibodies to Dsg 3 should have mucosal dominant PV because Dsg 1 compensates for the loss of Dsg 3 in the skin. Mucous membranes predominantly contain Dsg 3; low levels of Dsg 1 in the mucosa cannot replace the lost Dsg 3 and lead to epithelial acantholysis and mucosal erosions. When antibodies against both Dsg 1 and 3 develop, epidermal acantholysis occurs in both the skin and mucous membranes. It is still a matter of debate whether the Dsg compensation theory can adequately explain the complex pathogenic mechanism of pemphigus.
  • #20 Pemphigus Vulgaris | IntechOpen
    https://www.intechopen.com/chapters/81673
    The localization of blister formation and involvement of mucosal surfaces varies with the pemphigus disease subtype and can be explained by the Dsg compensation theory. This theory states that on cutaneous surfaces, Dsg 1 is expressed in all layers of the epidermis, while Dsg 3 is expressed in deeper layers. Dsg 1 expression in the mucosa is minimal, while Dsg 3 is dominant. The interpretation of the Dsg compensation theory, as it relates to the clinical manifestations in pemphigus, can be summarized as follows: Only patients with antibodies to Dsg 3 should have mucosal dominant PV because Dsg 1 compensates for the loss of Dsg 3 in the skin. Mucous membranes predominantly contain Dsg 3; low levels of Dsg 1 in the mucosa cannot replace the lost Dsg 3 and lead to epithelial acantholysis and mucosal erosions. When antibodies against both Dsg 1 and 3 develop, epidermal acantholysis occurs in both the skin and mucous membranes. It is still a matter of debate whether the Dsg compensation theory can adequately explain the complex pathogenic mechanism of pemphigus.
  • #21 Mechanisms of Disease: Pemphigus and Bullous Pemphigoid
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5560122/
    Abundant data suggest that some pemphigus antibodies directly interfere with cell adhesion. […] Mechanistically, some PV autoantibodies have been shown to interfere directly with homophilic trans-interaction of Dsg3 molecules, presumably through steric hindrance of Dsg adhesion. […] The model discussed here has been called the Dsg nonassembly depletion hypothesis. […] This model attributes loss of cell adhesion to the ability of multivalent pemphigus anti-Dsg antibodies to crosslink and cluster Dsgs. […] Early evidence implicating intracellular signaling mechanisms in induction of acantholysis came from the observation that polyclonal PV IgG causes retraction of keratin intermediate filaments in cultured keratinocytes from wild-type mice but not from PG-deficient mice. […] This signaling cascade was also shown to be active in PV and PF patients’ skin.
  • #22 Mechanisms of Disease: Pemphigus and Bullous Pemphigoid
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5560122/
    Abundant data suggest that some pemphigus antibodies directly interfere with cell adhesion. […] Mechanistically, some PV autoantibodies have been shown to interfere directly with homophilic trans-interaction of Dsg3 molecules, presumably through steric hindrance of Dsg adhesion. […] The model discussed here has been called the Dsg nonassembly depletion hypothesis. […] This model attributes loss of cell adhesion to the ability of multivalent pemphigus anti-Dsg antibodies to crosslink and cluster Dsgs. […] Early evidence implicating intracellular signaling mechanisms in induction of acantholysis came from the observation that polyclonal PV IgG causes retraction of keratin intermediate filaments in cultured keratinocytes from wild-type mice but not from PG-deficient mice. […] This signaling cascade was also shown to be active in PV and PF patients’ skin.
  • #23
    https://www.jci.org/articles/view/11828
    Desmogleins 1 and 3 are members of the cadherin family of adhesion molecules. They are transmembrane proteins that interact with plakoglobin, a component of the dense plaque of the desmosome. It is believed that antibodies to Dsg3 and Dsg1 directly induce acantholysis by interfering with the adhesive function of these target molecules. […] Induction of acantholysis is an active process that appears to be more complex than the simple interaction of antibodies with adhesion molecules. Signaling events associated with binding of PV sera to keratinocytes include activation of phospholipase C, resulting in increases in both inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). […] Grando and colleagues have proposed that blistering in PV is the result of synergy between anti-desmoglein antibodies and anticholinergic receptor antibodies. Antibodies to keratinocyte cholinergic receptors induce acantholysis, in this view, while antibodies to Dsg3 deplete Dsg3 from desmosomes. […] The work of Nguyen et al. raises a number of crucial questions about the pathogenesis of blistering in PV and PF.
  • #24 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://www.mdpi.com/2075-1729/11/7/621
    However, there is evidence also suggesting pemphigus blistering is not solely caused by autoantibody targeting to DSG3 but rather results from intracellular signaling mediated by non-DSGs targeting autoantibodies that leads to shrinkage of cell and apoptosis. […] The binding of PV IgG to DSG3 has been demonstrated to stimulate the phospholipase C signaling pathway which causes calcium release and PKC activation leading eventually to the desmosome and cell surface DSG3 depletion and the loss of intercellular cohesion and formation of blisters. […] DSG3 have been indicated as a key mediator involved in desmosome remodeling, epidermal proliferation and differentiation, cell migration and apoptosis, and thus validating that DSG3 acts as a signaling molecule that has a major impact on tissue integrity and homeostasis.
  • #25 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8303937/
    The immunobullous condition Pemphigus Vulgaris (PV) is caused by autoantibodies targeting the adhesion proteins of desmosomes, leading to blistering in the skin and mucosal membrane. […] Despite numerous investigations, the pathological mechanisms of PV are still incompletely understood, though the etiology is thought to be multifactorial. […] Ample studies have highlighted the role of Desmoglein-3 (DSG3) in the initiation of disease as DSG3 serves as a primary target of PV autoantibodies. […] Recent studies have uncovered new activities of DSG3 in regulating p53 and the yes-associated protein (YAP), with the evidence of dysregulation of these pathways demonstrated in PV. […] The pathological mechanisms of PV are controversial and remain a hot topic under debate in the field. […] Various signaling pathways are at play in the development of pemphigus acantholysis.
  • #26 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://www.mdpi.com/2075-1729/11/7/621
    The immunobullous condition Pemphigus Vulgaris (PV) is caused by autoantibodies targeting the adhesion proteins of desmosomes, leading to blistering in the skin and mucosal membrane. […] Despite numerous investigations, the pathological mechanisms of PV are still incompletely understood, though the etiology is thought to be multifactorial. […] Ample studies have highlighted the role of Desmoglein-3 (DSG3) in the initiation of disease as DSG3 serves as a primary target of PV autoantibodies. […] Recent studies have uncovered new activities of DSG3 in regulating p53 and the yes-associated protein (YAP), with the evidence of dysregulation of these pathways demonstrated in PV. […] The pathological mechanisms of PV are controversial and remain a hot topic under debate in the field. […] Ample studies support the concept that PV is caused by the pathogenic IgG autoantibodies directed against DSG3 as well as DSG1.
  • #27 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8303937/
    The phosphorylation of DSG3 is caused by the binding of pathogenic PV IgGs to DSG3 followed by its dissociation from plakoglobin and then endocytosis-mediated degradation. […] This theory explores new mechanisms with the findings obtained by independent groups. […] Rehman et al. have identified DSG3 acting as an anti-stress protein by counterbalancing p53 in the maintenance of normal epithelial homeostasis and demonstrated disruption of this regulation in PV. […] The study addresses the long-term controversy in the field of pemphigus research and fills the gap for the link between DSG3 and p53. […] It indicates that the loss/disruption of DSG3 alone is sufficient to induce aberrant p53 response and thus the disruption of DSG3 mediated intercellular junctions does not result solely from steric hindrance but rather causes dysfunction of cellular anti-stress response.
  • #28 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://www.mdpi.com/2075-1729/11/7/621
    The phosphorylation of DSG3 is caused by the binding of pathogenic PV IgGs to DSG3 followed by its dissociation from plakoglobin and then endocytosis-mediated degradation. […] Disruption of this remodeling process including the activation of the above-mentioned signaling pathways has been reported in PV. […] The apoptosis pathway in PV is proved by experimental studies that demonstrate that apoptotic signaling is activated by PV autoantibody and anti-Fas receptor (FasR) antibody. […] Rehman et al. have identified DSG3 acting as an anti-stress protein by counterbalancing p53 in the maintenance of normal epithelial homeostasis and demonstrated disruption of this regulation in PV. […] The study addresses the long-term controversy in the field of pemphigus research and fills the gap for the link between DSG3 and p53.
  • #29 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8303937/
    The phosphorylation of DSG3 is caused by the binding of pathogenic PV IgGs to DSG3 followed by its dissociation from plakoglobin and then endocytosis-mediated degradation. […] This theory explores new mechanisms with the findings obtained by independent groups. […] Rehman et al. have identified DSG3 acting as an anti-stress protein by counterbalancing p53 in the maintenance of normal epithelial homeostasis and demonstrated disruption of this regulation in PV. […] The study addresses the long-term controversy in the field of pemphigus research and fills the gap for the link between DSG3 and p53. […] It indicates that the loss/disruption of DSG3 alone is sufficient to induce aberrant p53 response and thus the disruption of DSG3 mediated intercellular junctions does not result solely from steric hindrance but rather causes dysfunction of cellular anti-stress response.
  • #30 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://www.mdpi.com/2075-1729/11/7/621
    The phosphorylation of DSG3 is caused by the binding of pathogenic PV IgGs to DSG3 followed by its dissociation from plakoglobin and then endocytosis-mediated degradation. […] Disruption of this remodeling process including the activation of the above-mentioned signaling pathways has been reported in PV. […] The apoptosis pathway in PV is proved by experimental studies that demonstrate that apoptotic signaling is activated by PV autoantibody and anti-Fas receptor (FasR) antibody. […] Rehman et al. have identified DSG3 acting as an anti-stress protein by counterbalancing p53 in the maintenance of normal epithelial homeostasis and demonstrated disruption of this regulation in PV. […] The study addresses the long-term controversy in the field of pemphigus research and fills the gap for the link between DSG3 and p53.
  • #31 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8303937/
    The phosphorylation of DSG3 is caused by the binding of pathogenic PV IgGs to DSG3 followed by its dissociation from plakoglobin and then endocytosis-mediated degradation. […] This theory explores new mechanisms with the findings obtained by independent groups. […] Rehman et al. have identified DSG3 acting as an anti-stress protein by counterbalancing p53 in the maintenance of normal epithelial homeostasis and demonstrated disruption of this regulation in PV. […] The study addresses the long-term controversy in the field of pemphigus research and fills the gap for the link between DSG3 and p53. […] It indicates that the loss/disruption of DSG3 alone is sufficient to induce aberrant p53 response and thus the disruption of DSG3 mediated intercellular junctions does not result solely from steric hindrance but rather causes dysfunction of cellular anti-stress response.
  • #32 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8303937/
    Hence, disruption of this pathway may play an important part in PV pathology. […] Collectively, it is likely that PV autoantibodies targeting DSG3 affect its function in the anti-stress network that leads to oxidative/antioxidative imbalance in cells. […] As a consequence, oxidative stress can occur in PV cells resulting in DSBs and hence the activation of a chain of reactions including ATM, c-Myc and p38 MAPK, and subsequently evokes the p53 pathway leading to deregulation of the apoptotic machinery and PV blistering. […] The pathological mechanisms underlying the pemphigus acantholysis are complex and remain not completely clear. […] Our recent studies shed new light on the unprecedented roles of DSG3 and suggest its mediated signaling towards p53, YAP and ROS in cellular stress response with the evidence of dysregulation of these axes being demonstrated in PV.
  • #33 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://www.mdpi.com/2075-1729/11/7/621
    Collectively, it is likely that PV autoantibodies targeting DSG3 affect its function in the anti-stress network that leads to oxidative/antioxidative imbalance in cells. […] Taken together, the above-discussed studies link together several unrelated pathways and open new avenues of research to investigate the pathogenesis and stress-induced tissue damage in PV.
  • #34 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8303937/
    Hence, disruption of this pathway may play an important part in PV pathology. […] Collectively, it is likely that PV autoantibodies targeting DSG3 affect its function in the anti-stress network that leads to oxidative/antioxidative imbalance in cells. […] As a consequence, oxidative stress can occur in PV cells resulting in DSBs and hence the activation of a chain of reactions including ATM, c-Myc and p38 MAPK, and subsequently evokes the p53 pathway leading to deregulation of the apoptotic machinery and PV blistering. […] The pathological mechanisms underlying the pemphigus acantholysis are complex and remain not completely clear. […] Our recent studies shed new light on the unprecedented roles of DSG3 and suggest its mediated signaling towards p53, YAP and ROS in cellular stress response with the evidence of dysregulation of these axes being demonstrated in PV.
  • #35 Up-regulation of ST18 in pemphigus vulgaris drives a self-amplifying p53-dependent pathomechanism resulting in decreased desmoglein 3 expression | Scientific Reports
    https://www.nature.com/articles/s41598-022-09951-x
    Pemphigus vulgaris (PV) is a life-threatening autoimmune mucocutaneous blistering disease which is to a large extent genetically determined, and results, at least in part, from the deleterious activity of autoantibodies directed against desmoglein (DSG)3, a prominent intra-epidermal adhesion molecule. […] We previously showed that rs17315309, a strong risk variant for PV within the promoter of the ST18 transcription factor gene, promotes epidermal ST18 up-regulation in a p53/p63-dependent manner. […] Increased ST18 expression was then shown to markedly augment PV autoantibodies-mediated loss of KCs cohesion. […] Here, we demonstrate that ST18 overexpression significantly increases autoantibody-mediated DSG3 down-regulation in keratinocytes. […] DSG3 decreased expression boosts p53 function through p38 mitogen-activated protein kinase (p38MAPK) activation and dramatically augments p53-dependent ST18 promoter activity.
  • #36 Up-regulation of ST18 in pemphigus vulgaris drives a self-amplifying p53-dependent pathomechanism resulting in decreased desmoglein 3 expression | Scientific Reports
    https://www.nature.com/articles/s41598-022-09951-x
    Pemphigus vulgaris (PV) is a life-threatening autoimmune mucocutaneous blistering disease which is to a large extent genetically determined, and results, at least in part, from the deleterious activity of autoantibodies directed against desmoglein (DSG)3, a prominent intra-epidermal adhesion molecule. […] We previously showed that rs17315309, a strong risk variant for PV within the promoter of the ST18 transcription factor gene, promotes epidermal ST18 up-regulation in a p53/p63-dependent manner. […] Increased ST18 expression was then shown to markedly augment PV autoantibodies-mediated loss of KCs cohesion. […] Here, we demonstrate that ST18 overexpression significantly increases autoantibody-mediated DSG3 down-regulation in keratinocytes. […] DSG3 decreased expression boosts p53 function through p38 mitogen-activated protein kinase (p38MAPK) activation and dramatically augments p53-dependent ST18 promoter activity.
  • #37 Up-regulation of ST18 in pemphigus vulgaris drives a self-amplifying p53-dependent pathomechanism resulting in decreased desmoglein 3 expression | Scientific Reports
    https://www.nature.com/articles/s41598-022-09951-x
    Pemphigus vulgaris (PV) is a life-threatening autoimmune mucocutaneous blistering disease which is to a large extent genetically determined, and results, at least in part, from the deleterious activity of autoantibodies directed against desmoglein (DSG)3, a prominent intra-epidermal adhesion molecule. […] We previously showed that rs17315309, a strong risk variant for PV within the promoter of the ST18 transcription factor gene, promotes epidermal ST18 up-regulation in a p53/p63-dependent manner. […] Increased ST18 expression was then shown to markedly augment PV autoantibodies-mediated loss of KCs cohesion. […] Here, we demonstrate that ST18 overexpression significantly increases autoantibody-mediated DSG3 down-regulation in keratinocytes. […] DSG3 decreased expression boosts p53 function through p38 mitogen-activated protein kinase (p38MAPK) activation and dramatically augments p53-dependent ST18 promoter activity.
  • #38 Up-regulation of ST18 in pemphigus vulgaris drives a self-amplifying p53-dependent pathomechanism resulting in decreased desmoglein 3 expression | Scientific Reports
    https://www.nature.com/articles/s41598-022-09951-x
    Finally, the PV risk variant rs17315309 is associated with increased p53 expression in PV skin. […] Here we demonstrate that ST18 overexpression steers a p53-dependent process resulting in enhanced autoantibody-mediated membranal DSG3 down-regulation in KCs, revealing a novel and pivotal self-perpetuating pathomechanism in PV. […] Given the fact that ST18 up-regulation increases anti-DSG3 antibodies-mediated DSG3 down-regulation and given the fact that ST18 expression is under p53 regulation, we next investigated the effect of autoantibody-mediated DSG3 down-regulation on p53 expression. […] We now show that ST18 induces DSG3 down-regulation, which in turn activates p53 which is required for ST18 up-regulation. […] The fact that DSG3 down-regulation stimulates p53 expression in a p38MAPK-dependent fashion sets the stage for a self-perpetuating mechanism which explains PV chronicity. Thus, ST18 plays a pivotal role in autoimmunity propagation in PV.
  • #39 Up-regulation of ST18 in pemphigus vulgaris drives a self-amplifying p53-dependent pathomechanism resulting in decreased desmoglein 3 expression | Scientific Reports
    https://www.nature.com/articles/s41598-022-09951-x
    Finally, the PV risk variant rs17315309 is associated with increased p53 expression in PV skin. […] Here we demonstrate that ST18 overexpression steers a p53-dependent process resulting in enhanced autoantibody-mediated membranal DSG3 down-regulation in KCs, revealing a novel and pivotal self-perpetuating pathomechanism in PV. […] Given the fact that ST18 up-regulation increases anti-DSG3 antibodies-mediated DSG3 down-regulation and given the fact that ST18 expression is under p53 regulation, we next investigated the effect of autoantibody-mediated DSG3 down-regulation on p53 expression. […] We now show that ST18 induces DSG3 down-regulation, which in turn activates p53 which is required for ST18 up-regulation. […] The fact that DSG3 down-regulation stimulates p53 expression in a p38MAPK-dependent fashion sets the stage for a self-perpetuating mechanism which explains PV chronicity. Thus, ST18 plays a pivotal role in autoimmunity propagation in PV.
  • #40 Pemphigus Vulgaris | IntechOpen
    https://www.intechopen.com/chapters/81673
    Intracellular kinase signaling has been identified in the pathogenic process of PV. The binding of autoantibodies in PV promotes phosphorylation of kinases. In the study in which patients with a diagnosis of PV were examined, kinases (e.g., phosphokinase C (PKC), p38 mitogen-activated protein kinase (p38MAPK), cyclin-dependent kinase (Cdk2), sarcoma-associated kinase (Src), extracellular signal-regulated kinase (ERK), Bruton tyrosine kinase (BTK), apoptosis signal regulatory kinase (ASK1), epidermal growth factor receptor kinase (EFGRK)), tyrosine kinase (TK)) were found to be phosphorylated in PV-induced models. Inhibition of these pathways reduces acantholysis in vitro and in vivo. The role of p38MAPK has been highlighted in multiple studies. p38MAPK is activated after PVIgG-binding upstream of Rho kinase. In particular, p38MAPK inhibition prevents PV-IgG-induced redistribution of Dsg3 and results in PV-IgG and Dsg3 co-localizing at the cell membrane. As a result, p38MAPK inhibition has been shown to prevent both histologic and clinical blister formation in both in vivo and in vitro models. Therefore, p38MAPK plays an essential role in regulating Dsg3 internalization and must be considered as a key component in PV pathogenicity.
  • #41 Pemphigus Vulgaris | IntechOpen
    https://www.intechopen.com/chapters/81673
    Intracellular kinase signaling has been identified in the pathogenic process of PV. The binding of autoantibodies in PV promotes phosphorylation of kinases. In the study in which patients with a diagnosis of PV were examined, kinases (e.g., phosphokinase C (PKC), p38 mitogen-activated protein kinase (p38MAPK), cyclin-dependent kinase (Cdk2), sarcoma-associated kinase (Src), extracellular signal-regulated kinase (ERK), Bruton tyrosine kinase (BTK), apoptosis signal regulatory kinase (ASK1), epidermal growth factor receptor kinase (EFGRK)), tyrosine kinase (TK)) were found to be phosphorylated in PV-induced models. Inhibition of these pathways reduces acantholysis in vitro and in vivo. The role of p38MAPK has been highlighted in multiple studies. p38MAPK is activated after PVIgG-binding upstream of Rho kinase. In particular, p38MAPK inhibition prevents PV-IgG-induced redistribution of Dsg3 and results in PV-IgG and Dsg3 co-localizing at the cell membrane. As a result, p38MAPK inhibition has been shown to prevent both histologic and clinical blister formation in both in vivo and in vitro models. Therefore, p38MAPK plays an essential role in regulating Dsg3 internalization and must be considered as a key component in PV pathogenicity.
  • #42 Pemphigus Vulgaris | IntechOpen
    https://www.intechopen.com/chapters/81673
    Intracellular kinase signaling has been identified in the pathogenic process of PV. The binding of autoantibodies in PV promotes phosphorylation of kinases. In the study in which patients with a diagnosis of PV were examined, kinases (e.g., phosphokinase C (PKC), p38 mitogen-activated protein kinase (p38MAPK), cyclin-dependent kinase (Cdk2), sarcoma-associated kinase (Src), extracellular signal-regulated kinase (ERK), Bruton tyrosine kinase (BTK), apoptosis signal regulatory kinase (ASK1), epidermal growth factor receptor kinase (EFGRK)), tyrosine kinase (TK)) were found to be phosphorylated in PV-induced models. Inhibition of these pathways reduces acantholysis in vitro and in vivo. The role of p38MAPK has been highlighted in multiple studies. p38MAPK is activated after PVIgG-binding upstream of Rho kinase. In particular, p38MAPK inhibition prevents PV-IgG-induced redistribution of Dsg3 and results in PV-IgG and Dsg3 co-localizing at the cell membrane. As a result, p38MAPK inhibition has been shown to prevent both histologic and clinical blister formation in both in vivo and in vitro models. Therefore, p38MAPK plays an essential role in regulating Dsg3 internalization and must be considered as a key component in PV pathogenicity.
  • #43 Pemphigus Vulgaris | IntechOpen
    https://www.intechopen.com/chapters/81673
    Intracellular kinase signaling has been identified in the pathogenic process of PV. The binding of autoantibodies in PV promotes phosphorylation of kinases. In the study in which patients with a diagnosis of PV were examined, kinases (e.g., phosphokinase C (PKC), p38 mitogen-activated protein kinase (p38MAPK), cyclin-dependent kinase (Cdk2), sarcoma-associated kinase (Src), extracellular signal-regulated kinase (ERK), Bruton tyrosine kinase (BTK), apoptosis signal regulatory kinase (ASK1), epidermal growth factor receptor kinase (EFGRK)), tyrosine kinase (TK)) were found to be phosphorylated in PV-induced models. Inhibition of these pathways reduces acantholysis in vitro and in vivo. The role of p38MAPK has been highlighted in multiple studies. p38MAPK is activated after PVIgG-binding upstream of Rho kinase. In particular, p38MAPK inhibition prevents PV-IgG-induced redistribution of Dsg3 and results in PV-IgG and Dsg3 co-localizing at the cell membrane. As a result, p38MAPK inhibition has been shown to prevent both histologic and clinical blister formation in both in vivo and in vitro models. Therefore, p38MAPK plays an essential role in regulating Dsg3 internalization and must be considered as a key component in PV pathogenicity.
  • #44 Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus | Scientific Reports
    https://www.nature.com/articles/s41598-017-03697-7
    Pemphigus is an autoimmune blistering skin disease caused primarily by autoantibodies against desmoglein (Dsg)1 and 3. Here, we characterized the mechanisms engaged by pemphigus IgG from patients with different clinical phenotypes and autoantibody profiles. All pemphigus vulgaris (PV) and pemphigus foliaceus (PF) IgG and AK23, a monoclonal mouse antibody against Dsg3, caused loss of cell cohesion, cytokeratin retraction and p38MAPK activation. Strong alterations in Dsg3 distribution were caused by mucosal (aDsg3 antibodies), mucocutaneous (aDsg1+aDsg3) as well as atypical (aDsg3) PV-IgG. All PV-IgG fractions and AK23 compromised Dsg3 but not Dsg1 binding and enhanced Src activity. In contrast, rapid Ca2+ influx and Erk activation were induced by mucocutaneous PV-IgG and pemphigus foliaceus (PF) IgG (aDsg1) whereas cAMP was increased by mucosal and mucocutaneous PV-IgG only. Selective inhibition of p38MAPK, Src or PKC blocked loss of keratinocyte cohesion in response to all autoantibody fractions whereas Erk inhibition was protective against mucocutaneous PV-IgG and PF-IgG only. These results demonstrate that signaling patterns parallel the clinical phenotype as some mechanisms involved in loss of cell cohesion are caused by antibodies targeting Dsg3 whereas others correlate with autoantibodies against Dsg1. The concept of key desmosome regulators may explain observations from several experimental models of pemphigus.
  • #45 Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus | Scientific Reports
    https://www.nature.com/articles/s41598-017-03697-7
    Pemphigus is an autoimmune blistering skin disease caused primarily by autoantibodies against desmoglein (Dsg)1 and 3. Here, we characterized the mechanisms engaged by pemphigus IgG from patients with different clinical phenotypes and autoantibody profiles. All pemphigus vulgaris (PV) and pemphigus foliaceus (PF) IgG and AK23, a monoclonal mouse antibody against Dsg3, caused loss of cell cohesion, cytokeratin retraction and p38MAPK activation. Strong alterations in Dsg3 distribution were caused by mucosal (aDsg3 antibodies), mucocutaneous (aDsg1+aDsg3) as well as atypical (aDsg3) PV-IgG. All PV-IgG fractions and AK23 compromised Dsg3 but not Dsg1 binding and enhanced Src activity. In contrast, rapid Ca2+ influx and Erk activation were induced by mucocutaneous PV-IgG and pemphigus foliaceus (PF) IgG (aDsg1) whereas cAMP was increased by mucosal and mucocutaneous PV-IgG only. Selective inhibition of p38MAPK, Src or PKC blocked loss of keratinocyte cohesion in response to all autoantibody fractions whereas Erk inhibition was protective against mucocutaneous PV-IgG and PF-IgG only. These results demonstrate that signaling patterns parallel the clinical phenotype as some mechanisms involved in loss of cell cohesion are caused by antibodies targeting Dsg3 whereas others correlate with autoantibodies against Dsg1. The concept of key desmosome regulators may explain observations from several experimental models of pemphigus.
  • #46 Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus | Scientific Reports
    https://www.nature.com/articles/s41598-017-03697-7
    Pemphigus is an autoimmune blistering skin disease caused primarily by autoantibodies against desmoglein (Dsg)1 and 3. Here, we characterized the mechanisms engaged by pemphigus IgG from patients with different clinical phenotypes and autoantibody profiles. All pemphigus vulgaris (PV) and pemphigus foliaceus (PF) IgG and AK23, a monoclonal mouse antibody against Dsg3, caused loss of cell cohesion, cytokeratin retraction and p38MAPK activation. Strong alterations in Dsg3 distribution were caused by mucosal (aDsg3 antibodies), mucocutaneous (aDsg1+aDsg3) as well as atypical (aDsg3) PV-IgG. All PV-IgG fractions and AK23 compromised Dsg3 but not Dsg1 binding and enhanced Src activity. In contrast, rapid Ca2+ influx and Erk activation were induced by mucocutaneous PV-IgG and pemphigus foliaceus (PF) IgG (aDsg1) whereas cAMP was increased by mucosal and mucocutaneous PV-IgG only. Selective inhibition of p38MAPK, Src or PKC blocked loss of keratinocyte cohesion in response to all autoantibody fractions whereas Erk inhibition was protective against mucocutaneous PV-IgG and PF-IgG only. These results demonstrate that signaling patterns parallel the clinical phenotype as some mechanisms involved in loss of cell cohesion are caused by antibodies targeting Dsg3 whereas others correlate with autoantibodies against Dsg1. The concept of key desmosome regulators may explain observations from several experimental models of pemphigus.
  • #47 Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus | Scientific Reports
    https://www.nature.com/articles/s41598-017-03697-7
    The signaling patterns identified here appear to be complex. Activation of p38MAPK was found under all pathological conditions which is in line with all publications where a role of this pathway in pemphigus pathogenesis has been reported downstream of PV-IgG, PF-IgG and AK23. This indicates that antibodies against Dsg3 as well as autoantibody fractions containing aDsg1 but not aDsg3 can activate p38MAPK signaling. […] The identification of signaling pathways activated by specific desmosomal and non-desmosomal autoantibodies should be a primary focus for future studies.
  • #48 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://www.mdpi.com/2075-1729/11/7/621
    The phosphorylation of DSG3 is caused by the binding of pathogenic PV IgGs to DSG3 followed by its dissociation from plakoglobin and then endocytosis-mediated degradation. […] Disruption of this remodeling process including the activation of the above-mentioned signaling pathways has been reported in PV. […] The apoptosis pathway in PV is proved by experimental studies that demonstrate that apoptotic signaling is activated by PV autoantibody and anti-Fas receptor (FasR) antibody. […] Rehman et al. have identified DSG3 acting as an anti-stress protein by counterbalancing p53 in the maintenance of normal epithelial homeostasis and demonstrated disruption of this regulation in PV. […] The study addresses the long-term controversy in the field of pemphigus research and fills the gap for the link between DSG3 and p53.
  • #49
    https://journals.lww.com/jpat/fulltext/2017/21020/current_concepts_of_pemphigus_with_a_deep_insight.15.aspx
    Pemphigus vulgaris is an autoimmune bullous disease involving both the skin and mucosal areas, which is characterized by intraepithelial flaccid blisters and erosions. The pathogenesis of this disease is not yet completely established, but novel intuitions into its pathogenesis have recently been published. An unanswered question in its pathophysiology is the mechanism of acantholysis or loss of keratinocyte cell adhesion. Acantholysis seems to result from a communal action of autoantibodies against numerous keratinocyte self-antigens, of which desmogleins 1 and 3, desmocollins and nondesmosome components, such as the mitochondrion, might take part in the disease initiation. […] Lately, apoptosis was described as a possible underlying mechanism of acantholysis. Likewise, apoptolysis is assumed to be the association between suprabasal acantholytic and cell death pathways.
  • #50
    https://journals.lww.com/jpat/fulltext/2017/21020/current_concepts_of_pemphigus_with_a_deep_insight.15.aspx
    This lesion also exhibits morphologically characteristic acantholysis due to loss of cell-cell adhesion among the keratinocytes. […] However, novel insights into Dsg biology and pemphigus pathology have been recommended, and new questions are evolving as the conventional concepts of the pathogenesis of pemphigus are being confronted. […] In the year 1881, the term acantholysis was coined by Auspitz, and it is derived from the Greek words Akantha, meaning a thorn or prickle, and lysis, i.e., loosening. Acantholysis means loss of coherence among epidermal cells due to the breakdown of intercellular bridges. […] Primary acantholysis refers to the dissociation and disintegration of desmosomes leading to the separation of keratinocytes which may be either due to the direct injury to desmosomes or due to the hereditary defects in their assembly. It is of key pathogenetic relevance in diseases of the pemphigus group.
  • #51 Pemphigus Vulgaris | IntechOpen
    https://www.intechopen.com/chapters/81673
    Caspases are involved in the pathogenesis of PV through apoptosis and acantholysis. Caspases are activated through various cellular pathways to affect programmed cell death. While apoptosis via caspases is a normal process in the body, the presence of PV-IgG causes pathological activation of caspases in keratinocytes. In all studies, inhibition of caspases has been shown to reduce apoptosis and acantholysis and thus have a positive effect on cell-cell adhesion. […] The pathogenesis of pemphigus involves the production of activated B-cells and IgG with stimulation by IL-4 by T-helper 2 (Th2) cells. Excessive activation of Th2 cells causes the production of autoantibodies required for PV. Th2 cells secrete IL-4 and multiple interleukins (IL), which are known to play an important role in pemphigus. IL-4 promotes antibody production by primed B cells and an isotype switching from IgG1 to IgG4 antibodies which are important in the active form of PV. IL-4 also causes naive CD4+ T cells to differentiate into Th2 cells, thus maintaining the disease. Production of autoantibodies and epitope binding are sufficient for the loss of adhesions directly between desmosomes.
  • #52 New insights into pyroptosis in pemphigus: from cellular structure to therapeutic targeting | Anais Brasileiros de Dermatologia
    https://www.anaisdedermatologia.org.br/en-new-insights-into-pyroptosis-in-avance-S0365059625000273
    Pemphigus is an autoimmune blistering disease where autoantibodies target desmoglein (Dsg) antigens on keratinocytes, triggering the p38 MAPK pathway, Dsg internalization, desmosomal dissolution, and keratinocyte apoptosis, are essential for blister formation. […] Recent research indicates keratinocyte pyroptosis may exacerbate acantholysis and delay wound healing. […] The present findings highlight a significant upregulation of pyroptosis-related proteins, which play a crucial role in the inflammatory response and blister formation characteristic of pemphigus. […] Pyroptosis significantly contributes to the pathogenesis of pemphigus and presents a promising target for therapy. […] Understanding the clinical implications of pyroptosis in pemphigus is essential. […] Pyroptosis is caused by the activation of inflammasomes via two major pathways: classical and non-classical.
  • #53 New insights into pyroptosis in pemphigus: from cellular structure to therapeutic targeting | Anais Brasileiros de Dermatologia
    https://www.anaisdedermatologia.org.br/en-new-insights-into-pyroptosis-in-avance-S0365059625000273
    Pemphigus is an autoimmune blistering disease where autoantibodies target desmoglein (Dsg) antigens on keratinocytes, triggering the p38 MAPK pathway, Dsg internalization, desmosomal dissolution, and keratinocyte apoptosis, are essential for blister formation. […] Recent research indicates keratinocyte pyroptosis may exacerbate acantholysis and delay wound healing. […] The present findings highlight a significant upregulation of pyroptosis-related proteins, which play a crucial role in the inflammatory response and blister formation characteristic of pemphigus. […] Pyroptosis significantly contributes to the pathogenesis of pemphigus and presents a promising target for therapy. […] Understanding the clinical implications of pyroptosis in pemphigus is essential. […] Pyroptosis is caused by the activation of inflammasomes via two major pathways: classical and non-classical.
  • #54 New insights into pyroptosis in pemphigus: from cellular structure to therapeutic targeting | Anais Brasileiros de Dermatologia
    https://www.anaisdedermatologia.org.br/en-new-insights-into-pyroptosis-in-avance-S0365059625000273
    Pemphigus is an autoimmune blistering disease where autoantibodies target desmoglein (Dsg) antigens on keratinocytes, triggering the p38 MAPK pathway, Dsg internalization, desmosomal dissolution, and keratinocyte apoptosis, are essential for blister formation. […] Recent research indicates keratinocyte pyroptosis may exacerbate acantholysis and delay wound healing. […] The present findings highlight a significant upregulation of pyroptosis-related proteins, which play a crucial role in the inflammatory response and blister formation characteristic of pemphigus. […] Pyroptosis significantly contributes to the pathogenesis of pemphigus and presents a promising target for therapy. […] Understanding the clinical implications of pyroptosis in pemphigus is essential. […] Pyroptosis is caused by the activation of inflammasomes via two major pathways: classical and non-classical.
  • #55 New insights into pyroptosis in pemphigus: from cellular structure to therapeutic targeting | Anais Brasileiros de Dermatologia
    https://www.anaisdedermatologia.org.br/en-new-insights-into-pyroptosis-in-avance-S0365059625000273
    Pemphigus is an autoimmune blistering disease where autoantibodies target desmoglein (Dsg) antigens on keratinocytes, triggering the p38 MAPK pathway, Dsg internalization, desmosomal dissolution, and keratinocyte apoptosis, are essential for blister formation. […] Recent research indicates keratinocyte pyroptosis may exacerbate acantholysis and delay wound healing. […] The present findings highlight a significant upregulation of pyroptosis-related proteins, which play a crucial role in the inflammatory response and blister formation characteristic of pemphigus. […] Pyroptosis significantly contributes to the pathogenesis of pemphigus and presents a promising target for therapy. […] Understanding the clinical implications of pyroptosis in pemphigus is essential. […] Pyroptosis is caused by the activation of inflammasomes via two major pathways: classical and non-classical.
  • #56 New insights into pyroptosis in pemphigus: from cellular structure to therapeutic targeting | Anais Brasileiros de Dermatologia
    https://www.anaisdedermatologia.org.br/en-new-insights-into-pyroptosis-in-avance-S0365059625000273
    The relationship between pyroptosis and acantholysis may primarily revolve around the inflammatory response triggered by pyroptosis and its detrimental impact on skin tissue integrity. […] Pyroptosis is commonly activated in response to intracellular pathogens, resulting in skin inflammation. […] Elevated levels of inflammatory cytokines, including IL-18 and IL-1, have been documented in several skin disorders, suggesting their potential role in linking pyroptosis to acantholysis. […] Exploring the role of pyroptosis in pemphigus pathogenesis and its therapeutic implications requires digging deeper into Caspase activation and how Caspase inhibitors, particularly those targeting Caspase-1, can help treat the disease. […] Recent research has revealed that innate immunity, including the recruitment of innate immune cells, the release of inflammatory mediators, and the activation of the complement system, also plays a significant role in the pathological process of pemphigus.
  • #57 New insights into pyroptosis in pemphigus: from cellular structure to therapeutic targeting | Anais Brasileiros de Dermatologia
    https://www.anaisdedermatologia.org.br/en-new-insights-into-pyroptosis-in-avance-S0365059625000273
    The relationship between pyroptosis and acantholysis may primarily revolve around the inflammatory response triggered by pyroptosis and its detrimental impact on skin tissue integrity. […] Pyroptosis is commonly activated in response to intracellular pathogens, resulting in skin inflammation. […] Elevated levels of inflammatory cytokines, including IL-18 and IL-1, have been documented in several skin disorders, suggesting their potential role in linking pyroptosis to acantholysis. […] Exploring the role of pyroptosis in pemphigus pathogenesis and its therapeutic implications requires digging deeper into Caspase activation and how Caspase inhibitors, particularly those targeting Caspase-1, can help treat the disease. […] Recent research has revealed that innate immunity, including the recruitment of innate immune cells, the release of inflammatory mediators, and the activation of the complement system, also plays a significant role in the pathological process of pemphigus.
  • #58 New insights into pyroptosis in pemphigus: from cellular structure to therapeutic targeting | Anais Brasileiros de Dermatologia
    https://www.anaisdedermatologia.org.br/en-new-insights-into-pyroptosis-in-avance-S0365059625000273
    The relationship between pyroptosis and acantholysis may primarily revolve around the inflammatory response triggered by pyroptosis and its detrimental impact on skin tissue integrity. […] Pyroptosis is commonly activated in response to intracellular pathogens, resulting in skin inflammation. […] Elevated levels of inflammatory cytokines, including IL-18 and IL-1, have been documented in several skin disorders, suggesting their potential role in linking pyroptosis to acantholysis. […] Exploring the role of pyroptosis in pemphigus pathogenesis and its therapeutic implications requires digging deeper into Caspase activation and how Caspase inhibitors, particularly those targeting Caspase-1, can help treat the disease. […] Recent research has revealed that innate immunity, including the recruitment of innate immune cells, the release of inflammatory mediators, and the activation of the complement system, also plays a significant role in the pathological process of pemphigus.
  • #59 New insights into pyroptosis in pemphigus: from cellular structure to therapeutic targeting | Anais Brasileiros de Dermatologia
    https://www.anaisdedermatologia.org.br/en-new-insights-into-pyroptosis-in-avance-S0365059625000273
    The relationship between pyroptosis and acantholysis may primarily revolve around the inflammatory response triggered by pyroptosis and its detrimental impact on skin tissue integrity. […] Pyroptosis is commonly activated in response to intracellular pathogens, resulting in skin inflammation. […] Elevated levels of inflammatory cytokines, including IL-18 and IL-1, have been documented in several skin disorders, suggesting their potential role in linking pyroptosis to acantholysis. […] Exploring the role of pyroptosis in pemphigus pathogenesis and its therapeutic implications requires digging deeper into Caspase activation and how Caspase inhibitors, particularly those targeting Caspase-1, can help treat the disease. […] Recent research has revealed that innate immunity, including the recruitment of innate immune cells, the release of inflammatory mediators, and the activation of the complement system, also plays a significant role in the pathological process of pemphigus.
  • #60 Mechanisms of Disease: Pemphigus and Bullous Pemphigoid
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5560122/
    There is a strong association between certain human leukocyte antigen (HLA) class II alleles and susceptibility to PV. […] These data suggest that patients who develop the disease must have HLA class II molecules capable of presenting Dsg3 peptides to T cells. […] To better understand the genetics and the precise function of human pemphigus antibodies, researchers have cloned anti-Dsg B cell repertoires from PV and PF patients to generate and analyze monoclonal antibodies. […] These studies suggest that there are specific clones of anti-Dsg B cells in pemphigus that may be eliminated with adequate treatment.
  • #61 Mechanisms of Disease: Pemphigus and Bullous Pemphigoid
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5560122/
    There is a strong association between certain human leukocyte antigen (HLA) class II alleles and susceptibility to PV. […] These data suggest that patients who develop the disease must have HLA class II molecules capable of presenting Dsg3 peptides to T cells. […] To better understand the genetics and the precise function of human pemphigus antibodies, researchers have cloned anti-Dsg B cell repertoires from PV and PF patients to generate and analyze monoclonal antibodies. […] These studies suggest that there are specific clones of anti-Dsg B cells in pemphigus that may be eliminated with adequate treatment.
  • #62 Pemphigus Vulgaris | IntechOpen
    https://www.intechopen.com/chapters/81673
    Caspases are involved in the pathogenesis of PV through apoptosis and acantholysis. Caspases are activated through various cellular pathways to affect programmed cell death. While apoptosis via caspases is a normal process in the body, the presence of PV-IgG causes pathological activation of caspases in keratinocytes. In all studies, inhibition of caspases has been shown to reduce apoptosis and acantholysis and thus have a positive effect on cell-cell adhesion. […] The pathogenesis of pemphigus involves the production of activated B-cells and IgG with stimulation by IL-4 by T-helper 2 (Th2) cells. Excessive activation of Th2 cells causes the production of autoantibodies required for PV. Th2 cells secrete IL-4 and multiple interleukins (IL), which are known to play an important role in pemphigus. IL-4 promotes antibody production by primed B cells and an isotype switching from IgG1 to IgG4 antibodies which are important in the active form of PV. IL-4 also causes naive CD4+ T cells to differentiate into Th2 cells, thus maintaining the disease. Production of autoantibodies and epitope binding are sufficient for the loss of adhesions directly between desmosomes.
  • #63 Pemphigus Vulgaris | IntechOpen
    https://www.intechopen.com/chapters/81673
    Caspases are involved in the pathogenesis of PV through apoptosis and acantholysis. Caspases are activated through various cellular pathways to affect programmed cell death. While apoptosis via caspases is a normal process in the body, the presence of PV-IgG causes pathological activation of caspases in keratinocytes. In all studies, inhibition of caspases has been shown to reduce apoptosis and acantholysis and thus have a positive effect on cell-cell adhesion. […] The pathogenesis of pemphigus involves the production of activated B-cells and IgG with stimulation by IL-4 by T-helper 2 (Th2) cells. Excessive activation of Th2 cells causes the production of autoantibodies required for PV. Th2 cells secrete IL-4 and multiple interleukins (IL), which are known to play an important role in pemphigus. IL-4 promotes antibody production by primed B cells and an isotype switching from IgG1 to IgG4 antibodies which are important in the active form of PV. IL-4 also causes naive CD4+ T cells to differentiate into Th2 cells, thus maintaining the disease. Production of autoantibodies and epitope binding are sufficient for the loss of adhesions directly between desmosomes.
  • #64 Pemphigus in India – Indian Journal of Dermatology, Venereology and Leprology
    https://ijdvl.com/pemphigus-in-india/
    Pemphigus being an autoimmune disease driven by autoantibody against epidermal antigen, it is expected from immunological point of view that Th2 predominance would be observed. […] The predominant subclass involved in pathogenesis of pemphigus is IgG 4 irrespective of type of pemphigus, as was assessed by direct immunofluorescence (DIF) as well as indirect immunofluorescence (IIF) study using normal human abdominal skin as substrate.
  • #65 Comprehensive review on the pathophysiology, clinical variants and management of pemphigus (Review)
    https://www.spandidos-publications.com/10.3892/etm.2021.10770
    Pemphigus represents a group of chronic inflammatory disorders characterized by autoantibodies that target components of desmosomes, leading to the loss of intercellular adhesion between keratinocytes and causing intraepithelial blistering. […] Genetic factors are involved in the pathogenesis, with HLADR4 (DRB1*0402) and HLADRw6 (DQB1*0503) allele more common in patients with pemphigus vulgaris, HLA class II DRB1*0344 and HLA Cw*1445 correlated with paraneoplastic pemphigus, and HLADRB1*04:01, HLADRB1*04:06, HLADRB1*01:01, HLADRB1*14, associated with a higher risk of developing pemphigus foliaceus. […] Autoantibodies are conducted against structural desmosomal proteins in the skin and mucous membranes, mainly desmogleins, desmocollins and plakins. […] The pathogenic role of these non-Dsg autoantibodies is mentioned by some studies, which suggest that they synergistically complement the classic effects of anti-Dsg autoantibodies in the complex process of pemphigus pathogenesis.
  • #66 Pemphigus in India – Indian Journal of Dermatology, Venereology and Leprology
    https://ijdvl.com/pemphigus-in-india/
    Pemphigus is a chronic autoimmune epidermal bullous disease caused by autoantibodies directed against desmogleins (Dsgs), that is, desmosomal glycoproteins expressed on the epithelial cells of the skin and mucosa, resulting in acantholysis. […] Apoptosis of keratinocytes may have a possible role in pathogenesis. […] Higher incidence of PV and earlier age at onset for pemphigus seen in Indian population have been attributed to higher frequency of DSG3FNx01TCCCC in Indian population. […] In an association analysis of intragenic single nucleotide polymorphism haplotypes to assess the contribution of Dsg 3 allele in susceptibility to PV, it was observed that two related haplotypes, DSG3FNx01TCCTC and DSG3FNx01TCCCC, were involved in the pathogenesis of PV in patients with British and North Indian descent, respectively.
  • #67 Transcriptomic profiling of pemphigus lesion infiltrating mononuclear cells reveals a distinct local immune microenvironment and novel lncRNA regulators | Journal of Translational Medicine | Full Text
    https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-022-03387-7
    Pemphigus is an autoimmune skin disease. Ectopic lymphoid-like structures (ELSs) were found to be commonly present in the pemphigus lesions, presumably supporting in situ desmoglein (Dsg)-specific antibody production. Yet functional phenotypes and the regulators of Lymphoid aggregates in pemphigus lesions remain largely unknown. […] Here, we provide the first transcriptomic characterization of lesion infiltrating immune cells which illustrates a distinct interplay network between adaptive and innate immune cells. It helps discover new regulators of local immune response, which potentially will provide a novel path forward to further uncover pemphigus pathological mechanisms and develop targeted therapy. […] Our findings corroborate the involvement of local immune dysregulation and altered Immune cell composition as potential drivers of pemphigus lesions. Moreover, we constructed a lncRNA-mediated competing endogenous RNA (ceRNA) network and identified epigenetic regulators, such as LINC01588 which might modulate Treg/Th17 balance via PPAR signaling pathway.
  • #68 Transcriptomic profiling of pemphigus lesion infiltrating mononuclear cells reveals a distinct local immune microenvironment and novel lncRNA regulators | Journal of Translational Medicine | Full Text
    https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-022-03387-7
    Pemphigus is an autoimmune skin disease. Ectopic lymphoid-like structures (ELSs) were found to be commonly present in the pemphigus lesions, presumably supporting in situ desmoglein (Dsg)-specific antibody production. Yet functional phenotypes and the regulators of Lymphoid aggregates in pemphigus lesions remain largely unknown. […] Here, we provide the first transcriptomic characterization of lesion infiltrating immune cells which illustrates a distinct interplay network between adaptive and innate immune cells. It helps discover new regulators of local immune response, which potentially will provide a novel path forward to further uncover pemphigus pathological mechanisms and develop targeted therapy. […] Our findings corroborate the involvement of local immune dysregulation and altered Immune cell composition as potential drivers of pemphigus lesions. Moreover, we constructed a lncRNA-mediated competing endogenous RNA (ceRNA) network and identified epigenetic regulators, such as LINC01588 which might modulate Treg/Th17 balance via PPAR signaling pathway.
  • #69 Transcriptomic profiling of pemphigus lesion infiltrating mononuclear cells reveals a distinct local immune microenvironment and novel lncRNA regulators | Journal of Translational Medicine | Full Text
    https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-022-03387-7
    We also compared the functional analysis results of SIMC with that of PBMC to better understand the unique roles of SIMC. The GO analysis results showed that PBMC had an over-representation of inflammatory cytokines and chemokines, while SIMC had a signature of neutrophil aggregations and other metabolism-related pathways. These results indicated that SIMC and PBMC had vastly different functional phenotypes. […] Interestingly, SIMC and PBMC shared similarity in the KEGG results. The IL-17 signaling pathway was over-represented in both SIMC and PBMC which is consistent with previous reports. […] Our study is also the first to demonstrate an increased infiltration of NK cell in pemphigus lesions. In addition, we found that LINC10588 was negatively correlated to PPAR signaling which may be related to the pathogenesis of pemphigus.
  • #70 Transcriptomic profiling of pemphigus lesion infiltrating mononuclear cells reveals a distinct local immune microenvironment and novel lncRNA regulators | Journal of Translational Medicine | Full Text
    https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-022-03387-7
    We also compared the functional analysis results of SIMC with that of PBMC to better understand the unique roles of SIMC. The GO analysis results showed that PBMC had an over-representation of inflammatory cytokines and chemokines, while SIMC had a signature of neutrophil aggregations and other metabolism-related pathways. These results indicated that SIMC and PBMC had vastly different functional phenotypes. […] Interestingly, SIMC and PBMC shared similarity in the KEGG results. The IL-17 signaling pathway was over-represented in both SIMC and PBMC which is consistent with previous reports. […] Our study is also the first to demonstrate an increased infiltration of NK cell in pemphigus lesions. In addition, we found that LINC10588 was negatively correlated to PPAR signaling which may be related to the pathogenesis of pemphigus.
  • #71 Transcriptomic profiling of pemphigus lesion infiltrating mononuclear cells reveals a distinct local immune microenvironment and novel lncRNA regulators | Journal of Translational Medicine | Full Text
    https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-022-03387-7
    We also compared the functional analysis results of SIMC with that of PBMC to better understand the unique roles of SIMC. The GO analysis results showed that PBMC had an over-representation of inflammatory cytokines and chemokines, while SIMC had a signature of neutrophil aggregations and other metabolism-related pathways. These results indicated that SIMC and PBMC had vastly different functional phenotypes. […] Interestingly, SIMC and PBMC shared similarity in the KEGG results. The IL-17 signaling pathway was over-represented in both SIMC and PBMC which is consistent with previous reports. […] Our study is also the first to demonstrate an increased infiltration of NK cell in pemphigus lesions. In addition, we found that LINC10588 was negatively correlated to PPAR signaling which may be related to the pathogenesis of pemphigus.
  • #72 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8303937/
    Hence, disruption of this pathway may play an important part in PV pathology. […] Collectively, it is likely that PV autoantibodies targeting DSG3 affect its function in the anti-stress network that leads to oxidative/antioxidative imbalance in cells. […] As a consequence, oxidative stress can occur in PV cells resulting in DSBs and hence the activation of a chain of reactions including ATM, c-Myc and p38 MAPK, and subsequently evokes the p53 pathway leading to deregulation of the apoptotic machinery and PV blistering. […] The pathological mechanisms underlying the pemphigus acantholysis are complex and remain not completely clear. […] Our recent studies shed new light on the unprecedented roles of DSG3 and suggest its mediated signaling towards p53, YAP and ROS in cellular stress response with the evidence of dysregulation of these axes being demonstrated in PV.
  • #73 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8303937/
    Hence, disruption of this pathway may play an important part in PV pathology. […] Collectively, it is likely that PV autoantibodies targeting DSG3 affect its function in the anti-stress network that leads to oxidative/antioxidative imbalance in cells. […] As a consequence, oxidative stress can occur in PV cells resulting in DSBs and hence the activation of a chain of reactions including ATM, c-Myc and p38 MAPK, and subsequently evokes the p53 pathway leading to deregulation of the apoptotic machinery and PV blistering. […] The pathological mechanisms underlying the pemphigus acantholysis are complex and remain not completely clear. […] Our recent studies shed new light on the unprecedented roles of DSG3 and suggest its mediated signaling towards p53, YAP and ROS in cellular stress response with the evidence of dysregulation of these axes being demonstrated in PV.
  • #74 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8303937/
    The immunobullous condition Pemphigus Vulgaris (PV) is caused by autoantibodies targeting the adhesion proteins of desmosomes, leading to blistering in the skin and mucosal membrane. […] Despite numerous investigations, the pathological mechanisms of PV are still incompletely understood, though the etiology is thought to be multifactorial. […] Ample studies have highlighted the role of Desmoglein-3 (DSG3) in the initiation of disease as DSG3 serves as a primary target of PV autoantibodies. […] Recent studies have uncovered new activities of DSG3 in regulating p53 and the yes-associated protein (YAP), with the evidence of dysregulation of these pathways demonstrated in PV. […] The pathological mechanisms of PV are controversial and remain a hot topic under debate in the field. […] Various signaling pathways are at play in the development of pemphigus acantholysis.
  • #75 Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8303937/
    The phosphorylation of DSG3 is caused by the binding of pathogenic PV IgGs to DSG3 followed by its dissociation from plakoglobin and then endocytosis-mediated degradation. […] This theory explores new mechanisms with the findings obtained by independent groups. […] Rehman et al. have identified DSG3 acting as an anti-stress protein by counterbalancing p53 in the maintenance of normal epithelial homeostasis and demonstrated disruption of this regulation in PV. […] The study addresses the long-term controversy in the field of pemphigus research and fills the gap for the link between DSG3 and p53. […] It indicates that the loss/disruption of DSG3 alone is sufficient to induce aberrant p53 response and thus the disruption of DSG3 mediated intercellular junctions does not result solely from steric hindrance but rather causes dysfunction of cellular anti-stress response.
  • #76
    https://journals.lww.com/jpat/fulltext/2017/21020/current_concepts_of_pemphigus_with_a_deep_insight.15.aspx
    Current evidence states that a part from the anti-Dsg1 and anti-Dsg3 antibodies, additional desmosomal, and nondesmosomal proteins such as cell-membrane receptors (nicotinic acetylcholine receptor, pemphaxin, thyroperoxidase and some other annexins) can be a target for the pemphigus. […] The current pemphigus research is clarifying new mechanisms of keratinocyte detachment in Pemphigus. Researches have put forward that apoptosis may possibly be responsible for the causal mechanisms of acantholysis. […] This results in the separation and splitting of preexisting desmosomes from the cell membrane by shear forces, thus entirely separating the collapsing cells and stimulating the production of scavenging antibodies. […] In conclusion, Dsgs are the key target antigens, though other autoantigens are also being explored. It is important that these autoantigens cannot elicit pemphigus alone without the presence of anti-Dsg antibodies; nonetheless, they may worsen the disease. Hence, this review summarizes that the structural damage (acantholysis) and death (apoptosis) of keratinocytes in pemphigus are intervened by the same set of cell death enzymes.
  • #77 Pemphigus Vulgaris | IntechOpen
    https://www.intechopen.com/chapters/81673
    Proteases are enzymes that hydrolyze peptide bonds within proteins. Proteases have been blamed because the use of various protease inhibitors was found to be effective in inhibiting PV-associated acantholysis in studies. Pemphigus antibodies (described as IgGp) may mediate acantholysis by the activation and release of non-lysosomal proteolytic enzymes from epidermal cells. Recent data indicate that the proteolytic enzyme is an activator of plasminogen. This has been demonstrated by the addition of a plasmin inhibitor such as aprotinin, which can inhibit the development of acantholysis when PV or PF IgG is added to the skin in organ cultures. Both plasminogen and IgG are required to cause acantholysis. […] There are many mechanisms in the pathogenesis of PV that are still not understood and more studies are needed.
  • #78 Comprehensive review on the pathophysiology, clinical variants and management of pemphigus (Review)
    https://www.spandidos-publications.com/10.3892/etm.2021.10770
    Research on some of these non-Dsg autoantibodies implies that they complement the typical effects of anti-Dsg autoantibodies in pemphigus pathogenesis. […] The etiopathogenesis of PNP is not completely known, but it is plausible that both autoantibodies and cell-mediated immunity play a key role. […] The most common autoantibodies detected in PNP are directed against the plakin family, such as envoplakin (210-kDa), periplakin (190-kDa), bullous pemphigoid antigen I (230-kDa), desmoplakin I (250-kDa), desmoplakin II (210-kDa), plectin (500-kDa), and 2-macroglobulin-like-1 (170-kDa). […] The exact pathomechanism of IgA pemphigus is not well defined, but it is related to IgA autoantibodies that target desmosomal and non-desmosomal keratinocyte cell surface components. […] The pathophysiology and autoantigen profile of bullous autoimmune diseases, especially pemphigus and its subforms, are more complex than previously assumed.